Safety of Extended-Interval Dosing Strategy of Immune Checkpoint Inhibitors for Advanced NSCLC

J Thorac Oncol. 2023 Feb;18(2):e14-e16. doi: 10.1016/j.jtho.2022.09.006.

¹ Service de Pneumologie, CHU Rennes, Rennes, France.
² Service de Pneumologie, CHU Rennes, Rennes, France; OSS (Oncogenesis Stress Signaling), Institut National de la Santé et de la Recherche Médicale (INSERM), Univ Rennes 1, Rennes, France.
³ Service de Pneumologie, CHU Rennes, Rennes, France; OSS (Oncogenesis Stress Signaling), Institut National de la Santé et de la Recherche Médicale (INSERM), Univ Rennes 1, Rennes, France. Electronic address: charles.ricordel@chu-rennes.fr.

No abstract available

Publication types